ALK rearrangement found in nearly 10 percent of patients in Lung Cancer Mutation Consortium

First Page		Document Content
Date: 2015-02-26 07:56:12 ALK inhibitor Anaplastic lymphoma kinase Crizotinib Non-small-cell lung carcinoma Cancer Metastasis EML4-ALK positive lung cancer AP26113 Medicine Lung cancer Organofluorides		ALK rearrangement found in nearly 10 percent of patients in Lung Cancer Mutation Consortium Add to Reading List Source URL: medicalxpress.com Download Document from Source Website File Size: 18,21 KB Share Document on Facebook

	Towards Personalized Cancer Therapy Using Delta-Reachability Analysis∗ Bing Liu Soonho Kong DocID: 1xVOI - View Document
	Alexis Kensinger -- Alexis’s Story – My name is Alexis Kensinger. When I was 18 years old and a senior in high school I was diagnosed with Stage 1 thyroid cancer. I was in a car accident 3 years prior to being diagno DocID: 1xVpQ - View Document
	DOI:http://dx.doi.orgAPJCPBlood Groups and Risk of Cancer: a Systematic Review and Meta-Analysis RESEARCH ARTICLE ABO Blood Groups and Risk of Cancer: a Systematic Review and Meta-analysis DocID: 1xVc0 - View Document
	Graphical Inference for Infovis Hadley Wickham, Dianne Cook, Heike Hofmann, and Andreas Buja Fig. 1. One of these plots doesn’t belong. These six plots show choropleth maps of cancer deaths in Texas, where darker color DocID: 1xV3p - View Document
	PDF Document DocID: 1xSgy - View Document